New Data Proves Effectiveness of Medtronic Insertable Cardiac Monitor in Detecting AF, Most Common Heart Rhythm Disorder Atrial fibrillation is the most common arrhythmia, affecting an estimated 7 million people worldwide, including 4.5 million in the European Union. Data presented today as a Hot Line session at the EUROPACE 2009 congress on the XPECT clinical trial, sponsored by Medtronic, Inc. , shows that the Medtronic Reveal XT Insertable Cardiac Monitor reliably identifies patients with AF and correctly confirms the absence of AF in patients. [more...]
